Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18726312eff9eb2bd2f380dd8189ec20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82B3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L21-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593 |
filingDate |
2005-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05a7555cda850eb42241c918429b20e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97daa56c8e623b3d70967a7c0e5938d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0b7755bbdf49e4a2fee33eb8d73453b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aee72b5c55a2ce186078d1f25ae22c74 |
publicationDate |
2007-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1758589-A1 |
titleOfInvention |
Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
abstract |
The present invention relates to a stable anhydrous pharmaceutical composition comprising a silicone agent comprising at least one organopolysiloxane elastomer and as active principles vitamin D or a vitamin D derivative and a corticosteroid, to the process for preparing it and to its use for the topical treatment of psoriasis and other skin disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265265-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9610245-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10154959-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065195-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9549896-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11696919-B2 |
priorityDate |
2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |